Financial Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules byJosh SandbergNovember 20, 2023
Recon First clinical use of intellijoint HIP’s® Direct Anterior Approach Application in Canada a success byJosh SandbergJuly 8, 2016
